Latent TB Infection Testing Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent TB Infection Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mantoux Test / Tuberculin Skin Test (TST)
1.2.3 Interferon-Gamma Release Assay (IGRA)
1.3 Market by Application
1.3.1 Global Latent TB Infection Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Public and Student Health
1.3.4 Physician Offices and Clinics
1.3.5 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Latent TB Infection Testing Market Perspective (2017-2028)
2.2 Latent TB Infection Testing Growth Trends by Region
2.2.1 Latent TB Infection Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Latent TB Infection Testing Historic Market Size by Region (2017-2022)
2.2.3 Latent TB Infection Testing Forecasted Market Size by Region (2023-2028)
2.3 Latent TB Infection Testing Market Dynamics
2.3.1 Latent TB Infection Testing Industry Trends
2.3.2 Latent TB Infection Testing Market Drivers
2.3.3 Latent TB Infection Testing Market Challenges
2.3.4 Latent TB Infection Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent TB Infection Testing Players by Revenue
3.1.1 Global Top Latent TB Infection Testing Players by Revenue (2017-2022)
3.1.2 Global Latent TB Infection Testing Revenue Market Share by Players (2017-2022)
3.2 Global Latent TB Infection Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Latent TB Infection Testing Revenue
3.4 Global Latent TB Infection Testing Market Concentration Ratio
3.4.1 Global Latent TB Infection Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent TB Infection Testing Revenue in 2021
3.5 Latent TB Infection Testing Key Players Head office and Area Served
3.6 Key Players Latent TB Infection Testing Product Solution and Service
3.7 Date of Enter into Latent TB Infection Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent TB Infection Testing Breakdown Data by Type
4.1 Global Latent TB Infection Testing Historic Market Size by Type (2017-2022)
4.2 Global Latent TB Infection Testing Forecasted Market Size by Type (2023-2028)
5 Latent TB Infection Testing Breakdown Data by Application
5.1 Global Latent TB Infection Testing Historic Market Size by Application (2017-2022)
5.2 Global Latent TB Infection Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Latent TB Infection Testing Market Size (2017-2028)
6.2 North America Latent TB Infection Testing Market Size by Type
6.2.1 North America Latent TB Infection Testing Market Size by Type (2017-2022)
6.2.2 North America Latent TB Infection Testing Market Size by Type (2023-2028)
6.2.3 North America Latent TB Infection Testing Market Share by Type (2017-2028)
6.3 North America Latent TB Infection Testing Market Size by Application
6.3.1 North America Latent TB Infection Testing Market Size by Application (2017-2022)
6.3.2 North America Latent TB Infection Testing Market Size by Application (2023-2028)
6.3.3 North America Latent TB Infection Testing Market Share by Application (2017-2028)
6.4 North America Latent TB Infection Testing Market Size by Country
6.4.1 North America Latent TB Infection Testing Market Size by Country (2017-2022)
6.4.2 North America Latent TB Infection Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Latent TB Infection Testing Market Size (2017-2028)
7.2 Europe Latent TB Infection Testing Market Size by Type
7.2.1 Europe Latent TB Infection Testing Market Size by Type (2017-2022)
7.2.2 Europe Latent TB Infection Testing Market Size by Type (2023-2028)
7.2.3 Europe Latent TB Infection Testing Market Share by Type (2017-2028)
7.3 Europe Latent TB Infection Testing Market Size by Application
7.3.1 Europe Latent TB Infection Testing Market Size by Application (2017-2022)
7.3.2 Europe Latent TB Infection Testing Market Size by Application (2023-2028)
7.3.3 Europe Latent TB Infection Testing Market Share by Application (2017-2028)
7.4 Europe Latent TB Infection Testing Market Size by Country
7.4.1 Europe Latent TB Infection Testing Market Size by Country (2017-2022)
7.4.2 Europe Latent TB Infection Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent TB Infection Testing Market Size (2017-2028)
8.2 Asia-Pacific Latent TB Infection Testing Market Size by Type
8.2.1 Asia-Pacific Latent TB Infection Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Latent TB Infection Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Latent TB Infection Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Latent TB Infection Testing Market Size by Application
8.3.1 Asia-Pacific Latent TB Infection Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Latent TB Infection Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Latent TB Infection Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Latent TB Infection Testing Market Size by Region
8.4.1 Asia-Pacific Latent TB Infection Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Latent TB Infection Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Latent TB Infection Testing Market Size (2017-2028)
9.2 Latin America Latent TB Infection Testing Market Size by Type
9.2.1 Latin America Latent TB Infection Testing Market Size by Type (2017-2022)
9.2.2 Latin America Latent TB Infection Testing Market Size by Type (2023-2028)
9.2.3 Latin America Latent TB Infection Testing Market Share by Type (2017-2028)
9.3 Latin America Latent TB Infection Testing Market Size by Application
9.3.1 Latin America Latent TB Infection Testing Market Size by Application (2017-2022)
9.3.2 Latin America Latent TB Infection Testing Market Size by Application (2023-2028)
9.3.3 Latin America Latent TB Infection Testing Market Share by Application (2017-2028)
9.4 Latin America Latent TB Infection Testing Market Size by Country
9.4.1 Latin America Latent TB Infection Testing Market Size by Country (2017-2022)
9.4.2 Latin America Latent TB Infection Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent TB Infection Testing Market Size (2017-2028)
10.2 Middle East & Africa Latent TB Infection Testing Market Size by Type
10.2.1 Middle East & Africa Latent TB Infection Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Latent TB Infection Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Latent TB Infection Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Latent TB Infection Testing Market Size by Application
10.3.1 Middle East & Africa Latent TB Infection Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Latent TB Infection Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Latent TB Infection Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Latent TB Infection Testing Market Size by Country
10.4.1 Middle East & Africa Latent TB Infection Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Latent TB Infection Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
11.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Details
11.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
11.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Introduction
11.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue in Latent TB Infection Testing Business (2017-2022)
11.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Developments
11.2 Pharmstandard (Generium Pharmaceutical)
11.2.1 Pharmstandard (Generium Pharmaceutical) Company Details
11.2.2 Pharmstandard (Generium Pharmaceutical) Business Overview
11.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Introduction
11.2.4 Pharmstandard (Generium Pharmaceutical) Revenue in Latent TB Infection Testing Business (2017-2022)
11.2.5 Pharmstandard (Generium Pharmaceutical) Recent Developments
11.3 Sanofi S.A./Sanofi Pasteur Ltd.
11.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Details
11.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
11.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Introduction
11.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Revenue in Latent TB Infection Testing Business (2017-2022)
11.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Recent Developments
11.4 Statens Serum Institut (SSI)
11.4.1 Statens Serum Institut (SSI) Company Details
11.4.2 Statens Serum Institut (SSI) Business Overview
11.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Introduction
11.4.4 Statens Serum Institut (SSI) Revenue in Latent TB Infection Testing Business (2017-2022)
11.4.5 Statens Serum Institut (SSI) Recent Developments
11.5 Autoimmun Diagnostika (AID) GmbH
11.5.1 Autoimmun Diagnostika (AID) GmbH Company Details
11.5.2 Autoimmun Diagnostika (AID) GmbH Business Overview
11.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Introduction
11.5.4 Autoimmun Diagnostika (AID) GmbH Revenue in Latent TB Infection Testing Business (2017-2022)
11.5.5 Autoimmun Diagnostika (AID) GmbH Recent Developments
11.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
11.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Details
11.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
11.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Introduction
11.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue in Latent TB Infection Testing Business (2017-2022)
11.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Developments
11.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
11.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Details
11.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
11.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Introduction
11.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue in Latent TB Infection Testing Business (2017-2022)
11.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Developments
11.8 Immunoshop India Pvt. Ltd.
11.8.1 Immunoshop India Pvt. Ltd. Company Details
11.8.2 Immunoshop India Pvt. Ltd. Business Overview
11.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Introduction
11.8.4 Immunoshop India Pvt. Ltd. Revenue in Latent TB Infection Testing Business (2017-2022)
11.8.5 Immunoshop India Pvt. Ltd. Recent Developments
11.9 Qiagen N.V.
11.9.1 Qiagen N.V. Company Details
11.9.2 Qiagen N.V. Business Overview
11.9.3 Qiagen N.V. Latent TB Infection Testing Introduction
11.9.4 Qiagen N.V. Revenue in Latent TB Infection Testing Business (2017-2022)
11.9.5 Qiagen N.V. Recent Developments
11.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
11.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Details
11.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
11.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Introduction
11.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue in Latent TB Infection Testing Business (2017-2022)
11.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Developments
11.11 SD Biosensor, Inc.
11.11.1 SD Biosensor, Inc. Company Details
11.11.2 SD Biosensor, Inc. Business Overview
11.11.3 SD Biosensor, Inc. Latent TB Infection Testing Introduction
11.11.4 SD Biosensor, Inc. Revenue in Latent TB Infection Testing Business (2017-2022)
11.11.5 SD Biosensor, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Latent TB Infection Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Mantoux Test / Tuberculin Skin Test (TST)
Table 3. Key Players of Interferon-Gamma Release Assay (IGRA)
Table 4. Global Latent TB Infection Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Latent TB Infection Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Latent TB Infection Testing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Latent TB Infection Testing Market Share by Region (2017-2022)
Table 8. Global Latent TB Infection Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Latent TB Infection Testing Market Share by Region (2023-2028)
Table 10. Latent TB Infection Testing Market Trends
Table 11. Latent TB Infection Testing Market Drivers
Table 12. Latent TB Infection Testing Market Challenges
Table 13. Latent TB Infection Testing Market Restraints
Table 14. Global Latent TB Infection Testing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Latent TB Infection Testing Revenue Share by Players (2017-2022)
Table 16. Global Top Latent TB Infection Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent TB Infection Testing as of 2021)
Table 17. Ranking of Global Top Latent TB Infection Testing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Latent TB Infection Testing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Latent TB Infection Testing Product Solution and Service
Table 21. Date of Enter into Latent TB Infection Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latent TB Infection Testing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Latent TB Infection Testing Revenue Market Share by Type (2017-2022)
Table 25. Global Latent TB Infection Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Latent TB Infection Testing Revenue Market Share by Type (2023-2028)
Table 27. Global Latent TB Infection Testing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Latent TB Infection Testing Revenue Share by Application (2017-2022)
Table 29. Global Latent TB Infection Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Latent TB Infection Testing Revenue Share by Application (2023-2028)
Table 31. North America Latent TB Infection Testing Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Latent TB Infection Testing Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Latent TB Infection Testing Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Latent TB Infection Testing Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Latent TB Infection Testing Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Latent TB Infection Testing Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Latent TB Infection Testing Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Latent TB Infection Testing Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Latent TB Infection Testing Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Latent TB Infection Testing Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Latent TB Infection Testing Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Latent TB Infection Testing Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Latent TB Infection Testing Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Latent TB Infection Testing Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Latent TB Infection Testing Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Latent TB Infection Testing Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Latent TB Infection Testing Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Latent TB Infection Testing Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Latent TB Infection Testing Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Latent TB Infection Testing Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Latent TB Infection Testing Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Latent TB Infection Testing Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Latent TB Infection Testing Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Latent TB Infection Testing Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Latent TB Infection Testing Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Latent TB Infection Testing Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Latent TB Infection Testing Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Latent TB Infection Testing Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Latent TB Infection Testing Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Latent TB Infection Testing Market Size by Country (2023-2028) & (US$ Million)
Table 61. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Details
Table 62. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
Table 63. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product
Table 64. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 65. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Developments
Table 66. Pharmstandard (Generium Pharmaceutical) Company Details
Table 67. Pharmstandard (Generium Pharmaceutical) Business Overview
Table 68. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product
Table 69. Pharmstandard (Generium Pharmaceutical) Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 70. Pharmstandard (Generium Pharmaceutical) Recent Developments
Table 71. Sanofi S.A./Sanofi Pasteur Ltd. Company Details
Table 72. Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
Table 73. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product
Table 74. Sanofi S.A./Sanofi Pasteur Ltd. Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 75. Sanofi S.A./Sanofi Pasteur Ltd. Recent Developments
Table 76. Statens Serum Institut (SSI) Company Details
Table 77. Statens Serum Institut (SSI) Business Overview
Table 78. Statens Serum Institut (SSI) Latent TB Infection Testing Product
Table 79. Statens Serum Institut (SSI) Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 80. Statens Serum Institut (SSI) Recent Developments
Table 81. Autoimmun Diagnostika (AID) GmbH Company Details
Table 82. Autoimmun Diagnostika (AID) GmbH Business Overview
Table 83. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product
Table 84. Autoimmun Diagnostika (AID) GmbH Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 85. Autoimmun Diagnostika (AID) GmbH Recent Developments
Table 86. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Details
Table 87. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
Table 88. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product
Table 89. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 90. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Developments
Table 91. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Details
Table 92. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
Table 93. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product
Table 94. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 95. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Developments
Table 96. Immunoshop India Pvt. Ltd. Company Details
Table 97. Immunoshop India Pvt. Ltd. Business Overview
Table 98. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product
Table 99. Immunoshop India Pvt. Ltd. Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 100. Immunoshop India Pvt. Ltd. Recent Developments
Table 101. Qiagen N.V. Company Details
Table 102. Qiagen N.V. Business Overview
Table 103. Qiagen N.V. Latent TB Infection Testing Product
Table 104. Qiagen N.V. Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 105. Qiagen N.V. Recent Developments
Table 106. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Details
Table 107. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
Table 108. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product
Table 109. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 110. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Developments
Table 111. SD Biosensor, Inc. Company Details
Table 112. SD Biosensor, Inc. Business Overview
Table 113. SD Biosensor, Inc. Latent TB Infection Testing Product
Table 114. SD Biosensor, Inc. Revenue in Latent TB Infection Testing Business (2017-2022) & (US$ Million)
Table 115. SD Biosensor, Inc. Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Latent TB Infection Testing Market Share by Type: 2021 VS 2028
Figure 2. Mantoux Test / Tuberculin Skin Test (TST) Features
Figure 3. Interferon-Gamma Release Assay (IGRA) Features
Figure 4. Global Latent TB Infection Testing Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Public and Student Health Case Studies
Figure 7. Physician Offices and Clinics Case Studies
Figure 8. Others (Military, Correctional Facilities, Chronic Care Homes, and Others) Case Studies
Figure 9. Latent TB Infection Testing Report Years Considered
Figure 10. Global Latent TB Infection Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Latent TB Infection Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Latent TB Infection Testing Market Share by Region: 2021 VS 2028
Figure 13. Global Latent TB Infection Testing Market Share by Players in 2021
Figure 14. Global Top Latent TB Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent TB Infection Testing as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Latent TB Infection Testing Revenue in 2021
Figure 16. North America Latent TB Infection Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Latent TB Infection Testing Market Size Market Share by Type (2017-2028)
Figure 18. North America Latent TB Infection Testing Market Size Market Share by Application (2017-2028)
Figure 19. North America Latent TB Infection Testing Market Size Share by Country (2017-2028)
Figure 20. United States Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Latent TB Infection Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Latent TB Infection Testing Market Size Market Share by Type (2017-2028)
Figure 24. Europe Latent TB Infection Testing Market Size Market Share by Application (2017-2028)
Figure 25. Europe Latent TB Infection Testing Market Size Share by Country (2017-2028)
Figure 26. Germany Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Latent TB Infection Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Latent TB Infection Testing Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Latent TB Infection Testing Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Latent TB Infection Testing Market Size Share by Region (2017-2028)
Figure 36. China Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Latent TB Infection Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Latent TB Infection Testing Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Latent TB Infection Testing Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Latent TB Infection Testing Market Size Share by Country (2017-2028)
Figure 46. Mexico Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Latent TB Infection Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Latent TB Infection Testing Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Latent TB Infection Testing Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Latent TB Infection Testing Market Size Share by Country (2017-2028)
Figure 52. Turkey Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Latent TB Infection Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 56. Pharmstandard (Generium Pharmaceutical) Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 57. Sanofi S.A./Sanofi Pasteur Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 58. Statens Serum Institut (SSI) Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 59. Autoimmun Diagnostika (AID) GmbH Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 60. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 61. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 62. Immunoshop India Pvt. Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 63. Qiagen N.V. Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 64. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 65. SD Biosensor, Inc. Revenue Growth Rate in Latent TB Infection Testing Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Industry Market Size
